Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$606.37 USD

606.37
378,357

-12.09 (-1.96%)

Updated Sep 12, 2024 12:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Medtronic (MDT) Releases Positive Study Results of RFA Therapy

Medtronic's (MDT) OsteoCool RFA System is expected to provide better relief from debilitating pain for cancer patients.

Here's Why You Should Add Hologic (HOLX) to Your Portfolio

Investors continue to be optimistic about Hologic (HOLX) on robust growth of the Diagnostics segment and regulatory approvals.

Here's Why You Should Hold onto Varian Medical (VAR) Stock Now

Investor confidence is high on Varian Medical (VAR) stock, courtesy of solid prospects.

Zimmer Biomet (ZBH) Shows Strong Recovery Amid COVID-19 Woes

Owing to lack of clarity around the scope and duration of the coronavirus pandemic, Zimmer Biomet (ZBH) is unable to gauge the impact on its overall business in 2020.

Abbott (ABT) Gains CE Mark for Quantitative Serology Testing

The test is set to be used on Abbott's (ABT) ARCHITECT and Alinity i platforms.

Veeva (VEEV) Vault QMS Gets Picked by Samsung Biologics

Veeva Systems' (VEEV) Vault Quality Suite gets selected by Samsung Biologics to drive quality process and content management for better visibility across the latter's global processes.

    Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

    AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.

      NextGen's (NXGN) HDH to Facilitate Health Information Exchange

      NextGen's (NXGN) HDH has been chosen by HI-BRIDGE HIE for secure sharing of patient health data from multiple sources.

        Abbott (ABT) Launches Immunity Boosting Hydration Solution

        Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.

        Masimo (MASI) Releases Favorable Findings on Pulse Oximetry

        Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.

        NEOGEN (NEOG) Launches DNA Screening Tool for Canine Care

        NEOGEN's (NEOG) latest DNA screening tool is expected to aid veterinarians to provide healthy lifestyle recommendations for a longer and happier life for each pet and its family.

        Here's Why You Should Retain Fresenius Medical (FMS) Stock

        Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

        Cerner's (CERN) Simplified Digital Tools to Aid Health Systems

        Cerner (CERN) offers centralized digital ordering and monitoring for clients in order to help health systems.

        Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

        Thermo Fisher Scientific (TMO) closed the most recent trading day at $471.39, moving +0.57% from the previous trading session.

        Zimmer Biomet (ZBH), HSS Partner to Advance Remote Patient Care

        Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.

        Here's Why You Should Hold on to McKesson (MCK) Stock Now

        McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

        Simbec-Orion to Adopt Veeva's (VEEV) Vault Applications

        Veeva's (VEEV) clinical solutions will offer Simbec-Orion real-time insights into studies in phases to accelerate trial execution.

        The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic

        The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic

        LabCorp's (LH) Pixel Kit Gets EUA for Over-the-Counter Use

        This approval is expected to increase access to LabCorp's (LH) COVID-19 testing, thereby broadening its customer base.

        Cerner's (CERN) Deal to Make Clinical Trials More Accessible

        Cerner (CERN) inks deal with Elligo Health Research to make clinical trials more accessible, while minimizing costs.

        Here's Why You Should Hold on to Nevro (NVRO) Stock Now

        Investors grew bullish on Nevro's (NVRO) prospects, courtesy of the stock's solid prospects.

        Zacks.com featured highlights include: Lennar Corp, TeleTech Holdings, Activision Blizzard, Thermo Fisher Scientific and ParkerHannifin

        Zacks.com featured highlights include: Lennar Corp, TeleTech Holdings, Activision Blizzard, Thermo Fisher Scientific and ParkerHannifin

        Medtronic (MDT) Carpediem to Tap Pediatric Kidney Care Market

        Medtronic's (MDT) Carpediem CRRT system compares favorably with the traditional three times a week therapy session.

          Bruker (BRKR) Hits New 52-Week High: What's Driving It?

          Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.

          Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access

          Illumina (ILMN) signs agreement to expand the availability of WGS to enable faster and cost-effective diagnosis of genetic diseases in children.